Icos Capital invests in ABOLIS

Abolis is already a major success story in European industrial biotech, with a strong track record of strategic and financial performance, and an impressive client base. Icos Capital is proud to be part of this growth financing round, which should propel Abolis to the next level. Icos Capital, along with its corporate partners such as Nouryon and Bühler, looks forward … Read More

Icos Capital, held the Icos Capital, held the “Collaborative Innovation Summit”at Bühler’s CUBIC Innovation

Uzwil (Switzerland), March 4, 2024 – The event brought together investors, industry leaders, and promising start-ups from the food, chemicals, and biotech sectors to accelerate sustainable solutions. The partners intend to grow their ecosystem of collaboration and innovation to enable start-ups to scale up their efforts in tackling some of the most urgent and complex challenges in the food and … Read More